- FOLFIRINOX or Gemcitabine Adjuvant Therapy for Cancer | NEJM
- Multisystem Inflammatory in Children (MIS-C) > Fact Sheets > Yale Medicine
- A to predict the risk of lupus enteritis in lupus erythematosus patients with involvement - EClinicalMedicine
- Case report and systematic suggest that children may experience similar long‐term effects to adults after clinical COVID‐19 - Ludvigsson - 2021 - Acta Paediatrica - Wiley Online Library
- Preseptal Cellulitis EyeWiki
- Eisenmenger Pathophysiology, Etiology
- MIS-C Review Finds Low Rate
- Factors linked to severe in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study - The Lancet & Adolescent Health
- - Gesundheitsprobleme von - Manual für Patienten
- Kawasaki Disease
- Oft Tetraeder Begleiten kawasaki sygdom smitte Prognose schlagen
- Aplastic anaemia: concepts in diagnosis and management - Furlong - 2020 - Journal of Paediatrics and Child - Wiley Online Library
- Kindern Jugendlichen | SpringerLink
- Frontiers | in COVID-19: An Up-To-Date Review | Pediatrics
- FOLFIRINOX or Gemcitabine Adjuvant Therapy for Cancer | NEJM
- PDF) infection and Kawasaki disease
- PPT KAWASAKI'S SYNDROM PowerPoint Presentation, free - ID:5178270
- PDF) [Kawasaki a coronavirus infection?]
- PDF) An evaluation of children with Kawasaki in Istanbul: A retrospective follow-up study
- FOLFIRINOX or Gemcitabine Adjuvant Therapy for Cancer | NEJM
- Oft Tetraeder Begleiten kawasaki sygdom smitte Prognose schlagen
- Clinical characteristics, treatment and outcomes of paediatric COVID-19: a review and meta-analysis | Archives of Disease in Childhood
- Kindern Jugendlichen | SpringerLink
- FOLFIRINOX or Gemcitabine Adjuvant Therapy for Cancer | NEJM
- Kawasaki-Syndrom - – Experteninformation